245 related articles for article (PubMed ID: 28456633)
1. Optineurin in amyotrophic lateral sclerosis: Multifunctional adaptor protein at the crossroads of different neuroprotective mechanisms.
Markovinovic A; Cimbro R; Ljutic T; Kriz J; Rogelj B; Munitic I
Prog Neurobiol; 2017 Jul; 154():1-20. PubMed ID: 28456633
[TBL] [Abstract][Full Text] [Related]
2. Functional analysis of optineurin and some of its disease-associated mutants.
Bansal M; Swarup G; Balasubramanian D
IUBMB Life; 2015 Feb; 67(2):120-8. PubMed ID: 25855473
[TBL] [Abstract][Full Text] [Related]
3. Defects in optineurin- and myosin VI-mediated cellular trafficking in amyotrophic lateral sclerosis.
Sundaramoorthy V; Walker AK; Tan V; Fifita JA; Mccann EP; Williams KL; Blair IP; Guillemin GJ; Farg MA; Atkin JD
Hum Mol Genet; 2015 Jul; 24(13):3830-46. PubMed ID: 25859013
[TBL] [Abstract][Full Text] [Related]
4. Dysfunction of Optineurin in Amyotrophic Lateral Sclerosis and Glaucoma.
Toth RP; Atkin JD
Front Immunol; 2018; 9():1017. PubMed ID: 29875767
[TBL] [Abstract][Full Text] [Related]
5. Mutations in the ubiquitin-binding domain of OPTN/optineurin interfere with autophagy-mediated degradation of misfolded proteins by a dominant-negative mechanism.
Shen WC; Li HY; Chen GC; Chern Y; Tu PH
Autophagy; 2015 Apr; 11(4):685-700. PubMed ID: 25484089
[TBL] [Abstract][Full Text] [Related]
6. Optineurin: A Coordinator of Membrane-Associated Cargo Trafficking and Autophagy.
Ryan TA; Tumbarello DA
Front Immunol; 2018; 9():1024. PubMed ID: 29867991
[TBL] [Abstract][Full Text] [Related]
7. Optineurin Insufficiency Disbalances Proinflammatory and Anti-inflammatory Factors by Reducing Microglial IFN-β Responses.
Markovinovic A; Ljutic T; Béland LC; Munitic I
Neuroscience; 2018 Sep; 388():139-151. PubMed ID: 30017954
[TBL] [Abstract][Full Text] [Related]
8. Optineurin Deficiency and Insufficiency Lead to Higher Microglial TDP-43 Protein Levels.
Prtenjaca N; Rob M; Alam MS; Markovinovic A; Stuani C; Buratti E; Munitic I
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743272
[TBL] [Abstract][Full Text] [Related]
9. Optineurin and amyotrophic lateral sclerosis.
Maruyama H; Kawakami H
Geriatr Gerontol Int; 2013 Jul; 13(3):528-32. PubMed ID: 23279185
[TBL] [Abstract][Full Text] [Related]
10. Dynamic recruitment and activation of ALS-associated TBK1 with its target optineurin are required for efficient mitophagy.
Moore AS; Holzbaur EL
Proc Natl Acad Sci U S A; 2016 Jun; 113(24):E3349-58. PubMed ID: 27247382
[TBL] [Abstract][Full Text] [Related]
11. Altered Functions and Interactions of Glaucoma-Associated Mutants of Optineurin.
Swarup G; Sayyad Z
Front Immunol; 2018; 9():1287. PubMed ID: 29951055
[TBL] [Abstract][Full Text] [Related]
12. Evidence of a link between ubiquilin 2 and optineurin in amyotrophic lateral sclerosis.
Osaka M; Ito D; Yagi T; Nihei Y; Suzuki N
Hum Mol Genet; 2015 Mar; 24(6):1617-29. PubMed ID: 25398946
[TBL] [Abstract][Full Text] [Related]
13. Nuclear factor κ B expression in patients with sporadic amyotrophic lateral sclerosis and hereditary amyotrophic lateral sclerosis with optineurin mutations.
Sako W; Ito H; Yoshida M; Koizumi H; Kamada M; Fujita K; Hashizume Y; Izumi Y; Kaji R
Clin Neuropathol; 2012; 31(6):418-23. PubMed ID: 22762947
[TBL] [Abstract][Full Text] [Related]
14. Optineurin: The autophagy connection.
Ying H; Yue BY
Exp Eye Res; 2016 Mar; 144():73-80. PubMed ID: 26142952
[TBL] [Abstract][Full Text] [Related]
15. Structural insights into the ubiquitin recognition by OPTN (optineurin) and its regulation by TBK1-mediated phosphorylation.
Li F; Xu D; Wang Y; Zhou Z; Liu J; Hu S; Gong Y; Yuan J; Pan L
Autophagy; 2018; 14(1):66-79. PubMed ID: 29394115
[TBL] [Abstract][Full Text] [Related]
16. [Identification of a new causative gene of amyotrophic lateral sclerosis; optineurin].
Maruyama H
Rinsho Shinkeigaku; 2012; 52(1):1-5. PubMed ID: 22260971
[TBL] [Abstract][Full Text] [Related]
17. Linear ubiquitination is involved in the pathogenesis of optineurin-associated amyotrophic lateral sclerosis.
Nakazawa S; Oikawa D; Ishii R; Ayaki T; Takahashi H; Takeda H; Ishitani R; Kamei K; Takeyoshi I; Kawakami H; Iwai K; Hatada I; Sawasaki T; Ito H; Nureki O; Tokunaga F
Nat Commun; 2016 Aug; 7():12547. PubMed ID: 27552911
[TBL] [Abstract][Full Text] [Related]
18. Significance of optineurin mutations in glaucoma and other diseases.
Minegishi Y; Nakayama M; Iejima D; Kawase K; Iwata T
Prog Retin Eye Res; 2016 Nov; 55():149-181. PubMed ID: 27693724
[TBL] [Abstract][Full Text] [Related]
19. A novel amyotrophic lateral sclerosis mutation in OPTN induces ER stress and Golgi fragmentation in vitro.
Fifita JA; Williams KL; Sundaramoorthy V; Mccann EP; Nicholson GA; Atkin JD; Blair IP
Amyotroph Lateral Scler Frontotemporal Degener; 2017 Feb; 18(1-2):126-133. PubMed ID: 27534431
[TBL] [Abstract][Full Text] [Related]
20. Optineurin with amyotrophic lateral sclerosis-related mutations abrogates inhibition of interferon regulatory factor-3 activation.
Sakaguchi T; Irie T; Kawabata R; Yoshida A; Maruyama H; Kawakami H
Neurosci Lett; 2011 Nov; 505(3):279-81. PubMed ID: 22040667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
